167 related articles for article (PubMed ID: 36476665)
1. Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study.
Wylegala A; Sripawadkul W; Zein M; Alvarez OP; Al Bayyat G; Galor A; Karp CL
Ocul Surf; 2023 Jan; 27():67-74. PubMed ID: 36476665
[TBL] [Abstract][Full Text] [Related]
2. Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia.
Sripawadkul W; Reyes-Capo D; Zein M; Wylegala A; Albayyat G; Galor A; Karp CL
Ocul Surf; 2023 Apr; 28():108-114. PubMed ID: 36592780
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
4. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
Joag MG; Sise A; Murillo JC; Sayed-Ahmed IO; Wong JR; Mercado C; Galor A; Karp CL
Ophthalmology; 2016 Jul; 123(7):1442-8. PubMed ID: 27030104
[TBL] [Abstract][Full Text] [Related]
5. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
Chaugule SS; Park J; Finger PT
Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
[TBL] [Abstract][Full Text] [Related]
6. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Sinha B; Kumar R
Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography angiography in the evaluation of vascular patterns of ocular surface squamous neoplasia during topical medical treatment.
Theotoka D; Liu Z; Wall S; Galor A; Al Bayyat GJ; Feuer W; Jianhua W; Karp CL
Ocul Surf; 2022 Jul; 25():8-18. PubMed ID: 35358712
[TBL] [Abstract][Full Text] [Related]
8. Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia.
Thomas BJ; Galor A; Nanji AA; El Sayyad F; Wang J; Dubovy SR; Joag MG; Karp CL
Ocul Surf; 2014 Jan; 12(1):46-58. PubMed ID: 24439046
[TBL] [Abstract][Full Text] [Related]
9. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
[TBL] [Abstract][Full Text] [Related]
10. Corneal squamous neoplasia: masquerades and management outcomes at a rural eyecare centre.
Agarwal A; Kaliki S; Murthy SI
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37130635
[TBL] [Abstract][Full Text] [Related]
11. Medical treatment for ocular surface squamous neoplasia.
Monroy D; Serrano A; Galor A; Karp CL
Eye (Lond); 2023 Apr; 37(5):885-893. PubMed ID: 36754986
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
13. Ocular surface squamous neoplasia: management and outcomes.
Hӧllhumer R; Williams S; Michelow P
Eye (Lond); 2021 Jun; 35(6):1562-1573. PubMed ID: 33564137
[TBL] [Abstract][Full Text] [Related]
14. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
Rudkin AK; Dempster L; Muecke JS
Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
[TBL] [Abstract][Full Text] [Related]
15. Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis.
Kozma K; Dömötör ZR; Csutak A; Szabó L; Hegyi P; Erőss B; Helyes Z; Molnár Z; Dembrovszky F; Szalai E
Sci Rep; 2022 Aug; 12(1):14221. PubMed ID: 35987957
[TBL] [Abstract][Full Text] [Related]
16. Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival/perilesional 5-fluorouracil injections.
Sun Y; Hua R
Drug Des Devel Ther; 2019; 13():1323-1334. PubMed ID: 31118569
[No Abstract] [Full Text] [Related]
17. Interferon Alfa-2b for Pigmented Ocular Surface Squamous Neoplasia: A Report of 8 Lesions.
Kaliki S; Sharma A; Vempuluru VS
Cornea; 2021 Feb; 40(2):142-146. PubMed ID: 32355112
[TBL] [Abstract][Full Text] [Related]
18. Observational study of ocular surface squamous neoplasia: Risk factors, diagnosis, management and outcomes at a tertiary eye hospital in South Africa.
Hӧllhumer R; Williams S; Michelow P
PLoS One; 2020; 15(8):e0237453. PubMed ID: 32780766
[TBL] [Abstract][Full Text] [Related]
19. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
Galor A; Karp CL; Oellers P; Kao AA; Abdelaziz A; Feuer W; Dubovy SR
Ophthalmology; 2012 Oct; 119(10):1974-81. PubMed ID: 22704832
[TBL] [Abstract][Full Text] [Related]
20. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
Krilis M; Tsang H; Coroneo M
Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
